Company Search:
Advanced Search
Sponsored Links
Avadel Pharmaceuticals PLC - ADR Company Snapshot
Avadel Pharmaceuticals PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Avadel Pharmaceuticals PLC with three other companies in this sector in the United States: NGM Biopharmaceuticals Inc (2018 sales of $108.67 million of which 100% was Clinical-stage biopharmaceutical company), Spectrum Pharmaceuticals, Inc. ($109.33 million of which 100% was Pharmaceuticals), and Melinta Therapeutics Inc ($96.43 million of which 100% was Pharmaceutical Preparations).

Sales Analysis. Avadel Pharmaceuticals PLC reported sales of $103.27 million for the year ending December of 2018. This represents a sharp decrease of 40.4% versus 2017, when the company's sales were $173.25 million. Contributing to the drop in overall sales was the 58.1% decline in Akovaz, from $80.62 million to $33.76 million. There were also decreases in sales in Bloxiverz (down 54.3% to $20.85 million) and Other (down 48.7% to $4.54 million) . However, these declines were partially offset by the increase in sales of Vazculep (up 12.4% to $42.92 million) .
  Stock Performance Chart for Avadel Pharmaceuticals PLC - ADR
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2020): 7.14
(Figures in U.S. Dollars)
1 Week 0.7%   13 Weeks -6.4%  
4 Weeks 43.1%   52 Weeks 227.5%  
Avadel Pharmaceuticals PLC - ADR Key Data:
  Ticker: AVDL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 103,269,108
(Year Ending Jan 2019).
Employees: 144
  Currency: U.S. Dollars Market Cap: 267,393,000
  Fiscal Yr Ends: December Shares Outstanding: 37,450,000
  Share Type: Ordinary Closely Held Shares: 857,553
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.